Загрузка...
Discordance between testosterone measurement methods in castrated prostate cancer patients
Failure to suppress testosterone below 0.7 nM in castrated prostate cancer patients is associated with poor clinical outcomes. Testosterone levels in castrated patients are therefore routinely measured. Although mass spectrometry is the gold standard used to measure testosterone, most hospitals use...
Сохранить в:
| Опубликовано в: : | Endocr Connect |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Bioscientifica Ltd
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6376995/ https://ncbi.nlm.nih.gov/pubmed/30673630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0476 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|